InflaRx NV (IFRX)
1.44
+0.01
(+0.70%)
USD |
NASDAQ |
May 31, 16:00
1.435
0.00 (0.00%)
After-Hours: 20:00
InflaRx Revenue (Annual): 0.0683M for Dec. 31, 2023
Revenue (Annual) Chart
Historical Revenue (Annual) Data
| Date | Value |
|---|---|
| December 31, 2023 | 0.0683M |
Revenues Definition
Revenues measure the total amount of value that a company brings in during a certain period. This is also considered the "top-line" of the income statement. Revenues are used for all operating expenses as well as other line items which eventually lead to the net income for the company. Revenue is an extremely important metric when analyzing a company. A company with efficient margins is able to turn revenues into the most net income.
Revenue (Annual) Range, Past 5 Years
0.0683M
Minimum
2023
0.0683M
Maximum
2023
0.0683M
Average
0.0683M
Median
2023
Revenue (Annual) Benchmarks
| Affimed NV | 8.959M |
| MorphoSys AG | 257.96M |
| BioNTech SE | 4.134B |
| Immatics NV | 58.46M |
| CureVac NV | 58.20M |